Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Ralph McCready

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|August 18, 2019
The 70th anniversary of automated radionuclide imagingV Ralph McCready
European Journal of Nuclear Medicine and Molecular Imaging|October 21, 2016
Radioiodine - the success story of Nuclear Medicine : 75th Anniversary of the first use of Iodine-131 in humansV Ralph McCready
European Journal of Nuclear Medicine and Molecular Imaging|September 27, 2018
Nuclear medicine RIP (radiation induced phobia); improving the imageV Ralph McCready, Sabina Dizdarevic
European Journal of Nuclear Medicine and Molecular Imaging|January 15, 2004
Complementary alternative medicine and nuclear medicineUrsula Werneke, V Ralph McCready
European Journal of Nuclear Medicine and Molecular Imaging|September 28, 2013
Diet and 18F bone imagingV Ralph McCready, Sabina Dizdarevic
European Journal of Nuclear Medicine and Molecular Imaging|January 3, 2024
Thyrotoxicosis is no insurance against thyroid cancerSabina Dizdarevic, V Ralph McCready, Mirza Skalonja
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 5, 2020
Lesion Detection and Administered ActivityV Ralph McCready, Sabina Dizdarevic, Thomas Beyer
European Journal of Nuclear Medicine and Molecular Imaging|May 4, 2013
Interventional nuclear medicineV Ralph McCready, Sabina Dizdarevic, Mark Aplin
Cancer Biotherapy & Radiopharmaceuticals|May 5, 2005
The potential use of 99mTc-MDP bone scans to plan high-activity 186Re-HEDP targeted therapy of bony metastases from prostate cancerDavid Binnie, Antigoni Divoli, V Ralph McCready, et al.
The British Journal of Radiology|January 3, 2018
Bone lesion absorbed dose profiles in patients with metastatic prostate cancer treated with molecular radiotherapyAna M Denis-Bacelar, Sarah J Chittenden, V Ralph McCready, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
European Journal of Nuclear Medicine and Molecular Imaging|August 18, 2019
The 70th anniversary of automated radionuclide imagingV Ralph McCready
European Journal of Nuclear Medicine and Molecular Imaging|October 21, 2016
Radioiodine - the success story of Nuclear Medicine : 75th Anniversary of the first use of Iodine-131 in humansV Ralph McCready
European Journal of Nuclear Medicine and Molecular Imaging|September 27, 2018
Nuclear medicine RIP (radiation induced phobia); improving the imageV Ralph McCready, Sabina Dizdarevic
European Journal of Nuclear Medicine and Molecular Imaging|January 15, 2004
Complementary alternative medicine and nuclear medicineUrsula Werneke, V Ralph McCready
European Journal of Nuclear Medicine and Molecular Imaging|September 28, 2013
Diet and 18F bone imagingV Ralph McCready, Sabina Dizdarevic
European Journal of Nuclear Medicine and Molecular Imaging|January 3, 2024
Thyrotoxicosis is no insurance against thyroid cancerSabina Dizdarevic, V Ralph McCready, Mirza Skalonja
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 5, 2020
Lesion Detection and Administered ActivityV Ralph McCready, Sabina Dizdarevic, Thomas Beyer
European Journal of Nuclear Medicine and Molecular Imaging|May 4, 2013
Interventional nuclear medicineV Ralph McCready, Sabina Dizdarevic, Mark Aplin
Cancer Biotherapy & Radiopharmaceuticals|May 5, 2005
The potential use of 99mTc-MDP bone scans to plan high-activity 186Re-HEDP targeted therapy of bony metastases from prostate cancerDavid Binnie, Antigoni Divoli, V Ralph McCready, et al.
The British Journal of Radiology|January 3, 2018
Bone lesion absorbed dose profiles in patients with metastatic prostate cancer treated with molecular radiotherapyAna M Denis-Bacelar, Sarah J Chittenden, V Ralph McCready, et al.
Pageof 2